8 January 2025
Shopping in Centre MK? Come and meet us…
Shoppers hitting the January sales at Centre:MK this weekend will have the opportunity to meet our team as Bedfordshire, Luton and Milton Keynes Integrated Care…
Alzheimer’s disease drug, lecanemab
Home >> news >> Alzheimer’s disease drug, lecanemab
An NHS spokesperson said:
“The NHS now awaits a final decision from the National Institute for Health and Care Excellence that will look at the clinical benefits and cost-effectiveness of lecanemab and determine if it should be routinely offered by the NHS in England.
“Lecanemab is the first disease modifying treatment for Alzheimer’s disease with a market approval in the UK, and to ensure the health system is prepared for future advances in treatments, a dedicated NHS team is also looking ahead to 27 other drugs which are currently in advanced clinical trials that could be potentially approved by 2030.”
View all news
Latest news and highlights
Case Study
7 January 2025
The Digitising Social Care programme at Bedfordshire, Luton and Milton Keynes Health and Care Partnership has been supporting care homes in Central Bedfordshire to adopt…
News
6 January 2025
Beat the cost of living crisis with help towards your health costs
Although most NHS treatment is free, there are still some costs you might need to pay. With many households still struggling with the cost of living, however, you may be…
News
2 January 2025
As the UK is expecting cold temperatures over the next week with the possibility of snow and ice, Bedfordshire, Luton and Milton Keynes Integrated Care Board (BLMK ICB) is urging…
News
2 January 2025
Ditch the blues and get moving
As January drags on and festive cheer feels like a distant memory, Bedfordshire, Luton and Milton Keynes Integrated Care Board is encouraging people to take part in Move It Monday,…
News
23 December 2024
An update on weight loss medication, tirzepatide
On 23 December 2024 the National Institute for Health and Care Excellence (NICE) published the Technology Appraisal in relation to tirzepatide (Mounjaro™) which is a new drug for managing obesity.…